Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester

Updated on: February 03,2024

Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester

Updated on:February 03,2024

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ

Updated on: February 01,2024

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ

Updated on:February 01,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on: November 11,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on:November 11,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on: January 29,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on:January 29,2024

Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on: January 16,2024

Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on:January 16,2024

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on: February 20,2024

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on:February 20,2024

Mutation analysis on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research paper was published inOncotargetentitled, "Mutation analysis performed on tumor biopsies from patients with newly

Updated on: January 15,2024

Mutation analysis on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research paper was published inOncotargetentitled, "Mutation analysis performed on tumor biopsies from patients with newly

Updated on:January 15,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on: April 18,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on:April 18,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on: January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on:January 22,2024

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on: September 07,2024

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on:September 07,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on: March 14,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on:March 14,2024